Imagen de Portada

Updates in pulmonary drug‐resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Dana J. Holger, Ali Althubyani, Taylor Morrisette, Nicholas Rebold, Marylee Tailor
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Oritavancin for Treatment of Osteomyelitis: A Systematic Review and Meta‐Analysis of Observational Studies
por: Martin Krsak, et al.
Publicado: (2025)

Scoping review of drug dosing recommendations in sustained low‐efficiency dialysis
por: Nicholas R. Nelson, et al.
Publicado: (2024)

Expert consensus recommendations for innovative antiretroviral drugs
por: C. Lindsay DeVane
Publicado: (2024)

Updates in chronic kidney disease management: A systematic review
por: Amina Ammar, et al.
Publicado: (2025)

Retrospective cohort study of oral switch versus intravenous antibiotics for carbapenem‐resistant enterobacterales and Pseudomonas aeruginosa infections on hospital discharge
por: Christen J. Arena, et al.
Publicado: (2025)

Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection
por: Shibing Tao, et al.
Publicado: (2024)

Update and narrative review of avian influenza (H5N1) infection in adult patients
por: Mohammed Aldhaeefi, et al.
Publicado: (2024)

GLP‐1RA‐induced delays in gastrointestinal motility: Predicted effects on coadministered drug absorption by PBPK analysis
por: Levi Hooper, et al.
Publicado: (2025)

Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
por: Mohammed Al Musawa, et al.
Publicado: (2024)

Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report
por: Atif Siddiqui
Publicado: (2024)

Comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
por: João Gama Marques, et al.
Publicado: (2025)

Efficacy and safety of mirikizumab compared with currently approved biologic drugs for the treatment of ulcerative colitis: A systematic review and network meta‐analysis
por: Paweł Moćko, et al.
Publicado: (2024)

Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
por: Atif Siddiqui
Publicado: (2025)

Association between gastroprotective agents and acute kidney injury in patients receiving non‐steroidal anti‐inflammatory drugs: Analysis of a Japanese hospital‐based database
por: Satoru Mitsuboshi, et al.
Publicado: (2024)

Combination eravacycline therapy for ventilator‐associated pneumonia due to carbapenem‐resistant Acinetobacter baumannii in patients with COVID‐19: A case series
por: Melissa N. W. Jackson, et al.
Publicado: (2024)

Pharmacokinetic and pharmacodynamic evaluation of sulbactam‐durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem‐resistant Acinetobacter baumannii‐calcoaceticus complex
por: Wesley D. Kufel, et al.
Publicado: (2025)

Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects
por: Shawn Flanagan, et al.
Publicado: (2024)

Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy
por: David B. Cluck, et al.
Publicado: (2024)

Pain management considerations in patients living with both pain syndromes and cardiovascular diseases and disorders
por: Emily E. Leppien, et al.
Publicado: (2024)

Adverse events with co‐prescription of angiotensin receptor blockers and clarithromycin compared to azithromycin: A population‐based retrospective cohort study
por: Nicholas C. Tonial, et al.
Publicado: (2025)

Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis
por: Susan E. Smith, et al.
Publicado: (2026)

Pharmacotherapeutic Controversies During Temperature Control After Out‐of‐Hospital Cardiac Arrest: A Semi‐Structured Literature Review
por: Christy Cecil Forehand, et al.
Publicado: (2026)

Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia
por: Rachel D. Harris, et al.
Publicado: (2024)

Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
por: Alexandre Duong, et al.
Publicado: (2024)

Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
por: Maryam Aghakouchakzadeh, et al.
Publicado: (2026)

Cancer Treatment Modalities and Female Fertility Preservation
por: Seonga Song, et al.
Publicado: (2026)

Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report
por: Jiwon Kim, et al.
Publicado: (2025)

Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers
por: Hua‐Ping Fan, et al.
Publicado: (2024)

Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
por: Keith A. Rodvold
Publicado: (2026)

Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report
por: Nicolette Centanni, et al.
Publicado: (2025)

Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
por: Yi‐Fan Chien, et al.
Publicado: (2025)

Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
por: Amanda Massmann, et al.
Publicado: (2025)

In Search of Big Beautiful Biomarkers
por: C. Lindsay DeVane
Publicado: (2025)

“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
por: Carlos Augusto Espinoza Cobeñas
Publicado: (2024)

Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
por: Lisa T. Hong, et al.
Publicado: (2024)

Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics
por: Nihal El Rouby, et al.
Publicado: (2025)

Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics
por: Trisha Matsuura, et al.
Publicado: (2025)

Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug‐Resistant Epilepsy: A Double‐Blind Placebo‐Controlled Trial
por: Amira R. Rashdan, et al.
Publicado: (2026)

A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial
por: Kathleen A. Stringer, et al.
Publicado: (2025)

Oral β‐Lactams for Complicated Urinary Tract Infections: A Systematic Review and Point‐Counterpoint Comparison With Trimethoprim/Sulfamethoxazole and Fluoroquinolones
por: Ashlan J. Kunz Coyne, et al.
Publicado: (2026)